title: [Effection of observation Xinnaoxin capsules in treatment of chronic cerebral circulatory insufficiency].
abstract: OBJECTIVE
  To observe the therapeutic effect of Xinnaoxin capsules in patients with chronic cerebral circulatory insufficiency.
  
  
  METHODS
  Patients with chronic cerebral circulatory insufficiency were divided randomly into two groups: a Xinnaoxin capsules group (n = 60, treated by Xinnaoxin capsules for four 4 weeks), a control group (n = 58, treated by Nimodiping for four weeks). The transcranial doppler (TCD) was used to determined mean velocity (Vm) and auto-viscometer measured hemorheological indices before and after being treated.
  
  
  RESULTS
  After 4 weeks treatment, the hemorheological indices and mean velocity were obviously improve in Xinnaoxin capsules group (P <0.05), there is significant difference between the effective rate of two groups (88.3%, 70.7%).
  
  
  CONCLUSIONS
  Our study suggest that Xinnaoxin capsules have therapeutic function on chronic cerebral circulatory insufficiency.
authors.affiliation: Affiliated Hospital of Youjiang Medical College for Nationalities, Baise 533000, China. lanqingmeng@sina.com
authors.forename: Lan-qing
authors.initials: LQ
authors.lastname: Meng
authors.forename: Rui-ya
authors.initials: RY
authors.lastname: Huang
authors.forename: Ye-sheng
authors.initials: YS
authors.lastname: Wei
authors.forename: Shi-ge
authors.initials: SG
authors.lastname: Wei
authors.forename: Xue-bin
authors.initials: XB
authors.lastname: Li
authors.forename: Jian-min
authors.initials: JM
authors.lastname: Huang
mesh_terms: D001783:Blood Flow Velocity / Q000187:drug effects; D002214:Capsules; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000000981:diagnostic imaging / Q000188:drug therapy*; D004338:Drug Combinations; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage / Q000302:isolation & purification / Q000627:therapeutic use*; D005260:Female; D031281:Hippophae / Q000737:chemistry; D006801:Humans; D032305:Lycium / Q000737:chemistry; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D010946:Plants, Medicinal / Q000737:chemistry*; D029771:Rhodiola / Q000737:chemistry; D016896:Treatment Outcome; D017585:Ultrasonography, Doppler, Transcranial
chemical_list: D002214:Capsules; D004338:Drug Combinations; D004365:Drugs, Chinese Herbal; C532977:xinnaoxin